{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T17:51:49Z","timestamp":1768240309508,"version":"3.49.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100031886","name":"Scottish Rite for Children","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031886","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Pediatric Orthopaedic Society of North America"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jposna.2025.100202","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T12:17:10Z","timestamp":1748002630000},"page":"100202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Molecular Basis of Fracture Pseudarthrosis Associated with Neurofibromatosis Type 1"],"prefix":"10.1016","volume":"12","author":[{"given":"Aysha","family":"Khalid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nandina","family":"Paria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0969-2184","authenticated-orcid":false,"given":"Jonathan J.","family":"Rios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jposna.2025.100202_bib1","doi-asserted-by":"crossref","first-page":"17004","DOI":"10.1038\/nrdp.2017.4","article-title":"Neurofibromatosis type 1","volume":"3","author":"Gutmann","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jposna.2025.100202_bib2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1126\/science.2134734","article-title":"Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients","volume":"249","author":"Wallace","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.jposna.2025.100202_bib3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0092-8674(90)90252-A","article-title":"Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus","volume":"62","author":"Viskochil","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.jposna.2025.100202_bib4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0092-8674(90)90253-B","article-title":"A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations","volume":"62","author":"Cawthon","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.jposna.2025.100202_bib5","doi-asserted-by":"crossref","first-page":"9914","DOI":"10.1073\/pnas.88.22.9914","article-title":"Identification and characterization of the neurofibromatosis type 1 protein product","volume":"88","author":"DeClue","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jposna.2025.100202_bib6","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/356713a0","article-title":"Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients","volume":"356","author":"Basu","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.jposna.2025.100202_bib7","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41436-021-01170-5","article-title":"Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation","volume":"23","author":"Legius","year":"2021","journal-title":"Genet Med"},{"key":"10.1016\/j.jposna.2025.100202_bib8","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s00198-004-1801-4","article-title":"Decreased bone mineral density and content in neurofibromatosis type 1: lowest local values are located in the load-carrying parts of the body","volume":"16","author":"Kuorilehto","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jposna.2025.100202_bib9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ymgme.2007.12.004","article-title":"Generalized metabolic bone disease in Neurofibromatosis type I","volume":"94","author":"Brunetti-Pierri","year":"2008","journal-title":"Mol Genet Metabol"},{"key":"10.1016\/j.jposna.2025.100202_bib10","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/(SICI)1096-8628(20000529)92:3<224::AID-AJMG12>3.0.CO;2-J","article-title":"Growth charts for young children with neurofibromatosis 1 (NF1)","volume":"92","author":"Szudek","year":"2000","journal-title":"Am J Med Genet"},{"issue":"Suppl 2","key":"10.1016\/j.jposna.2025.100202_bib11","first-page":"289","article-title":"Growth and pubertal disorders in neurofibromatosis type 1","volume":"16","author":"Virdis","year":"2003","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.jposna.2025.100202_bib12","first-page":"9","article-title":"Early-onset spinal deformity in neurofibromatosis type 1: natural history, treatment, and imaging surveillance","author":"Marrache","year":"2021","journal-title":"JBJS Rev"},{"key":"10.1016\/j.jposna.2025.100202_bib13","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ocl.2007.03.008","article-title":"Scoliosis associated with neurofibromatosis","volume":"38","author":"Crawford","year":"2007","journal-title":"Orthop Clin N Am"},{"key":"10.1016\/j.jposna.2025.100202_bib14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00586-004-0829-7","article-title":"Spinal deformity in neurofibromatosis type-1: diagnosis and treatment","volume":"14","author":"Tsirikos","year":"2005","journal-title":"Eur Spine J"},{"key":"10.1016\/j.jposna.2025.100202_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/(SICI)1096-8628(19990326)89:1<31::AID-AJMG7>3.0.CO;2-W","article-title":"Plexiform neurofibromas","volume":"89","author":"Korf","year":"1999","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jposna.2025.100202_bib16","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1038\/s41436-020-0885-3","article-title":"A molecular basis for neurofibroma-associated skeletal manifestations in NF1","volume":"22","author":"Ma","year":"2020","journal-title":"Genet Med"},{"key":"10.1016\/j.jposna.2025.100202_bib17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5435\/00124635-199907000-00002","article-title":"Neurofibromatosis in children: the role of the orthopaedist","volume":"7","author":"Crawford","year":"1999","journal-title":"J Am Acad Orthop Surg"},{"key":"10.1016\/j.jposna.2025.100202_bib18","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.2106\/JBJS.20.00657","article-title":"Distal tibial guided growth for anterolateral bowing of the tibia: fracture may Be prevented","volume":"102","author":"Laine","year":"2020","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.jposna.2025.100202_bib19","doi-asserted-by":"crossref","first-page":"e560","DOI":"10.1097\/BPO.0000000000002683","article-title":"Guided growth to treat anterolateral tibial bowing associated with congenital pseudarthrosis of the tibia","volume":"44","author":"Todderud","year":"2024","journal-title":"J Pediatr Orthop"},{"key":"10.1016\/j.jposna.2025.100202_bib20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/BPO.0b013e31828121b8","article-title":"Approaches to treating NF1 tibial pseudarthrosis: consensus from the children\u2019s tumor foundation NF1 bone abnormalities consortium","volume":"33","author":"Stevenson","year":"2013","journal-title":"J Pediatr Orthop"},{"key":"10.1016\/j.jposna.2025.100202_bib21","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1097\/BPO.0000000000001650","article-title":"Are some randomized clinical trials impossible?","volume":"41","author":"Rios","year":"2020","journal-title":"J Pediatr Orthop"},{"key":"10.1016\/j.jposna.2025.100202_bib22","first-page":"3","article-title":"Complex decisions in the management of congenital pseudarthrosis of the tibia","author":"Laine","year":"2021","journal-title":"JPOSNA"},{"key":"10.1016\/j.jposna.2025.100202_bib23","doi-asserted-by":"crossref","first-page":"e630","DOI":"10.1097\/BPO.0000000000002148","article-title":"Does an osteotomy performed in congenital pseudarthrosis of the tibia heal?","volume":"42","author":"Nahm","year":"2022","journal-title":"J Pediatr Orthop"},{"key":"10.1016\/j.jposna.2025.100202_bib24","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41588-025-02097-2","article-title":"Cancer-independent somatic mutation of the wild-type NF1 allele in normal tissues in neurofibromatosis type 1","volume":"57","author":"Oliver","year":"2025","journal-title":"Nat Genet"},{"key":"10.1016\/j.jposna.2025.100202_bib25","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/jor.22121","article-title":"Is double inactivation of the Nf1 gene responsible for the development of congenital pseudarthrosis of the tibia associated with NF1?","volume":"30","author":"Lee","year":"2012","journal-title":"J Orthop Res"},{"key":"10.1016\/j.jposna.2025.100202_bib26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1086\/504441","article-title":"Double inactivation of NF1 in tibial pseudarthrosis","volume":"79","author":"Stevenson","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jposna.2025.100202_bib27","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1002\/jbmr.2298","article-title":"Neurofibromin deficiency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1","volume":"29","author":"Paria","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jposna.2025.100202_bib28","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/jbmr.4755","article-title":"Kidane Y.H.,et al. Molecular dissection of somatic skeletal disease in neurofibromatosis type 1","volume":"38","author":"Paria","year":"2023","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jposna.2025.100202_bib29","doi-asserted-by":"crossref","first-page":"eadj1597","DOI":"10.1126\/scitranslmed.adj1597","article-title":"MEK-SHP2 inhibition prevents tibial pseudarthrosis caused by NF1 loss in Schwann cells and skeletal stem\/progenitor cells","volume":"16","author":"Perrin","year":"2024","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jposna.2025.100202_bib30","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.2106\/JBJS.24.01007","article-title":"Molecular evidence supporting MEK inhibitor therapy in NF1 pseudarthrosis","volume":"107","author":"Paria","year":"2025","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.jposna.2025.100202_bib31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bone.2017.10.012","article-title":"The reduced osteogenic potential of Nf1-deficient osteoprogenitors is EGFR-independent","volume":"106","author":"Tahaei","year":"2018","journal-title":"Bone"},{"key":"10.1016\/j.jposna.2025.100202_bib32","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1101\/gad.8.9.1019","article-title":"Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues","volume":"8","author":"Brannan","year":"1994","journal-title":"Genes Dev"},{"key":"10.1016\/j.jposna.2025.100202_bib33","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/ng0794-353","article-title":"Tumour predisposition in mice heterozygous for a targeted mutation in Nf1","volume":"7","author":"Jacks","year":"1994","journal-title":"Nat Genet"},{"key":"10.1016\/j.jposna.2025.100202_bib34","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1101\/gad.862101","article-title":"Rushing E.J.,et al. Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain","volume":"15","author":"Zhu","year":"2001","journal-title":"Genes Dev"},{"key":"10.1016\/j.jposna.2025.100202_bib35","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.bone.2011.08.021","article-title":"Genetic mouse models for bone studies--strengths and limitations","volume":"49","author":"Elefteriou","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.jposna.2025.100202_bib36","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/jbmr.4415","article-title":"Sites of Cre-recombinase activity in mouse lines targeting skeletal cells","volume":"36","author":"Couasnay","year":"2021","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jposna.2025.100202_bib37","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/hmg\/ddm032","article-title":"Wilkening U.,et al. Multiple roles for neurofibromin in skeletal development and growth","volume":"16","author":"Kolanczyk","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jposna.2025.100202_bib38","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1093\/hmg\/ddr310","article-title":"Mice lacking Nf1 in osteochondroprogenitor cells display skeletal dysplasia similar to patients with neurofibromatosis type I","volume":"20","author":"Wang","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jposna.2025.100202_bib39","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nm.3583","article-title":"Perrien D.S.,et al. Asfotase-alpha improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1","volume":"20","author":"de la Croix Ndong","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.jposna.2025.100202_bib40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jbmr.2316","article-title":"Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -\/- mice","volume":"30","author":"de la Croix Ndong","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jposna.2025.100202_bib41","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/jbmr.4633","article-title":"Elefteroiu F.,et al. Identifying bone matrix impairments in a mouse model of neurofibromatosis type 1 (NF1) by clinically translatable techniques","volume":"37","author":"Ahmed","year":"2022","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jposna.2025.100202_bib42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01202412-200001000-00002","article-title":"Pathology of bone lesions associated with congenital pseudarthrosis of the leg","volume":"9","author":"Ippolito","year":"2000","journal-title":"J Pediatr Orthop B"},{"key":"10.1016\/j.jposna.2025.100202_bib43","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1093\/hmg\/ddz095","article-title":"Mund J.,et al. Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation","volume":"28","author":"Rhodes","year":"2019","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jposna.2025.100202_bib44","article-title":"The haploinsufficient hematopoietic microenvironment is critical to the pathological fracture repair in murine models of neurofibromatosis type 1","volume":"6","author":"Wu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jposna.2025.100202_bib45","first-page":"9","article-title":"Spatial transcriptomics implicates impaired BMP signaling in NF1 fracture pseudarthrosis in murine and patient tissues","author":"Rios","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.jposna.2025.100202_bib46","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.92519","article-title":"Single-nucleus transcriptomics reveal the differentiation trajectories of periosteal skeletal\/stem progenitor cells in bone regeneration","volume":"13","author":"Perrin","year":"2024","journal-title":"eLife"},{"key":"10.1016\/j.jposna.2025.100202_bib47","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41467-018-03124-z","article-title":"Cagnard N.,et al. Periosteum contains skeletal stem cells with high bone regenerative potential controlled by Periostin","volume":"9","author":"Duchamp de Lageneste","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jposna.2025.100202_bib48","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41586-018-0554-8","article-title":"Discovery of a periosteal stem cell mediating intramembranous bone formation","volume":"562","author":"Debnath","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jposna.2025.100202_bib49","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.stem.2022.10.002","article-title":"Bone marrow and periosteal skeletal stem\/progenitor cells make distinct contributions to bone maintenance and repair","volume":"29","author":"Jeffery","year":"2022","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jposna.2025.100202_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/children8070547","article-title":"Cross-union surgery for congenital pseudarthrosis of the tibia","volume":"8","author":"Shannon","year":"2021","journal-title":"Children"},{"key":"10.1016\/j.jposna.2025.100202_bib51","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/BPO.0b013e318221ebce","article-title":"4-in-1 osteosynthesis\u201d for atrophic-type congenital pseudarthrosis of the tibia","volume":"31","author":"Choi","year":"2011","journal-title":"J Pediatr Orthop"},{"key":"10.1016\/j.jposna.2025.100202_bib52","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2106\/JBJS.H.01667","article-title":"The use of rhBMP-2 for the treatment of congenital pseudarthrosis of the tibia: a case series","volume":"92","author":"Richards","year":"2010","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.jposna.2025.100202_bib53","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/BPO.0000000000000789","article-title":"rhBMP-2 and intramedullary fixation in congenital pseudarthrosis of the tibia","volume":"38","author":"Richards","year":"2018","journal-title":"J Pediatr Orthop"},{"key":"10.1016\/j.jposna.2025.100202_bib54","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12891-024-08257-5","article-title":"Efficacy of the cross-union protocol in the treatment of congenital tibial pseudarthrosis: a comparative study","volume":"26","author":"Jing","year":"2025","journal-title":"BMC Muscoskelet Disord"},{"key":"10.1016\/j.jposna.2025.100202_bib55","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11832-012-0421-3","article-title":"Masquelet's procedure and bone morphogenetic protein in congenital pseudarthrosis of the tibia in children: a case series and meta-analysis","volume":"6","author":"Dohin","year":"2012","journal-title":"J Child Orthop"},{"key":"10.1016\/j.jposna.2025.100202_bib56","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s11832-013-0499-2","article-title":"Congenital pseudarthrosis of the tibia: the results of an evolving protocol of management","volume":"7","author":"Nicolaou","year":"2013","journal-title":"J Child Orthop"},{"key":"10.1016\/j.jposna.2025.100202_bib57","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1302\/0301-620X.93B5.25938","article-title":"Combined treatment of congenital pseudarthrosis of the tibia, including recombinant human bone morphogenetic protein-2: a case series","volume":"93","author":"Spiro","year":"2011","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.jposna.2025.100202_bib58","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.1097\/BPO.0000000000001172","article-title":"What factors influence union and refracture of congenital pseudarthrosis of the tibia? A multicenter long-term study","volume":"38","author":"Shah","year":"2018","journal-title":"J Pediatr Orthop"}],"container-title":["Journal of the Pediatric Orthopaedic Society of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S276827652500046X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S276827652500046X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T14:18:54Z","timestamp":1768227534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S276827652500046X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":58,"alternative-id":["S276827652500046X"],"URL":"https:\/\/doi.org\/10.1016\/j.jposna.2025.100202","relation":{},"ISSN":["2768-2765"],"issn-type":[{"value":"2768-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular Basis of Fracture Pseudarthrosis Associated with Neurofibromatosis Type 1","name":"articletitle","label":"Article Title"},{"value":"Journal of the Pediatric Orthopaedic Society of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jposna.2025.100202","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of Pediatric Orthopaedic Society of North America.","name":"copyright","label":"Copyright"}],"article-number":"100202"}}